• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[异基因造血干细胞移植无关供者选择：法语国家骨髓移植与细胞治疗协会（SFGM-TC）指南]

[Unrelated donor selection for allogeneic hematopoietic stem cell transplantation: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].

作者信息

Cornillon Jérôme, Crocchiolo Roberto, Dubois Valérie, Guidicelli Gwendaline, Jorge-Cordeiro Debora, Meunier Marie-Christine, Michiels Sandra, Timmermans Aurélie, Villemonteix Juliette, Yakoub-Agha Ibrahim, Ahmad Imran

机构信息

Centre hospitalo-universitaire de Saint-Étienne 42, département d'hématologie et de thérapie cellulaire, Saint-Étienne, France.

SIMT, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italie.

出版信息

Bull Cancer. 2024 Feb;111(2S):S1-S13. doi: 10.1016/j.bulcan.2023.07.008. Epub 2023 Sep 9.

DOI:10.1016/j.bulcan.2023.07.008
PMID:37690877
Abstract

The selection of a donor is an essential element in allogeneic hematopoietic stem cell transplantation. In the absence of an HLA-matched related donor, the selection of an unrelated donor is considered, and is currently the most common type of allogenic donor used in practice. Many criteria are considered for the selection when multiple donors are available, particularly in case of partial match. The aim of this workshop is to assist in the selection of an unrelated donor, in keeping with recent data from the literature.

摘要

供体的选择是异基因造血干细胞移植的一个关键要素。在没有HLA匹配的亲属供体的情况下，会考虑选择非亲属供体，且其目前是实践中最常用的同种异体供体类型。当有多个供体可供选择时，尤其是在部分匹配的情况下，选择时会考虑许多标准。本次研讨会的目的是根据文献中的最新数据协助选择非亲属供体。

相似文献

1
[Unrelated donor selection for allogeneic hematopoietic stem cell transplantation: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].[异基因造血干细胞移植无关供者选择：法语国家骨髓移植与细胞治疗协会（SFGM-TC）指南]
Bull Cancer. 2024 Feb;111(2S):S1-S13. doi: 10.1016/j.bulcan.2023.07.008. Epub 2023 Sep 9.
2
[Haploidentical hematopoietic stem cell transplantation: Guidelines from the Francophone society of marrow transplantation and cellular therapy (SFGM-TC)].[单倍型相合造血干细胞移植：法语国家骨髓移植与细胞治疗协会（SFGM-TC）指南]
Bull Cancer. 2016 Nov;103(11S):S229-S242. doi: 10.1016/j.bulcan.2016.09.007. Epub 2016 Nov 11.
3
[Secondary cancers following allogeneic hematopoietic stem cell transplantation: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].[异基因造血干细胞移植后的继发性癌症：法语国家骨髓移植与细胞治疗协会（SFGM-TC）指南]
Bull Cancer. 2024 Feb;111(2S):S22-S28. doi: 10.1016/j.bulcan.2023.02.016. Epub 2023 Mar 13.
4
[Indications and follow-up for autologous hematopoietic stem cell transplantation in multiple sclerosis: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) in association with the Francophone Society of Multiple Sclerosis].[多发性硬化症自体造血干细胞移植的适应症及随访：法语国家骨髓移植与细胞治疗协会（SFGM-TC）与法语国家多发性硬化症协会联合发布的指南]
Bull Cancer. 2019 Jan;106(1S):S92-S101. doi: 10.1016/j.bulcan.2018.11.002. Epub 2018 Dec 5.
5
[Vaccination of allogeneic haematopoietic stem cell transplant recipients: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].[异基因造血干细胞移植受者的疫苗接种：法语国家骨髓移植与细胞治疗协会（SFGM-TC）指南]
Bull Cancer. 2024 Feb;111(2S):S40-S49. doi: 10.1016/j.bulcan.2023.05.007. Epub 2023 Jul 19.
6
[Mobilization and conditioning protocols actualization for autologous stem cell transplantation for autoimmune diseases: Guidelines from MATHEC-SFGM-TC].[自身免疫性疾病自体干细胞移植的动员与预处理方案实施：MATHEC-SFGM-TC指南]
Bull Cancer. 2024 Feb;111(2S):S84-S95. doi: 10.1016/j.bulcan.2023.09.002. Epub 2023 Oct 14.
7
[Stem cell transplantation unit: Guidelines from the francophone Society of bone marrow transplantation and cellular therapy (SFGM-TC)].[干细胞移植单元：来自法语国家骨髓移植与细胞治疗协会（SFGM-TC）的指南]
Bull Cancer. 2019 Jan;106(1S):S1-S9. doi: 10.1016/j.bulcan.2018.11.005. Epub 2018 Dec 21.
8
[Polymorphism in HLA and KIR genes and the impact on hematopoietic stem cell transplantation outcomes and unrelated donor selection: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].[人类白细胞抗原（HLA）和杀伤细胞免疫球蛋白样受体（KIR）基因多态性及其对造血干细胞移植结局和无关供体选择的影响：法语国家骨髓移植和细胞治疗协会（SFGM-TC）指南]
Bull Cancer. 2016 Nov;103(11S):S243-S247. doi: 10.1016/j.bulcan.2016.09.005. Epub 2016 Nov 14.
9
[Haploidentical hematopoietic stem cell transplant: How to choose the best donor? Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].[单倍型相合造血干细胞移植：如何选择最佳供者？法语国家骨髓移植与细胞治疗协会（SFGM-TC）指南]
Bull Cancer. 2020 Jan;107(1S):S72-S84. doi: 10.1016/j.bulcan.2019.07.011. Epub 2019 Oct 2.
10
[National patient follow-up care logbook: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].[国家患者随访护理日志：法语国家骨髓移植与细胞治疗协会（SFGM-TC）指南]
Bull Cancer. 2021 Dec;108(12S):S87-S89. doi: 10.1016/j.bulcan.2021.07.004. Epub 2021 Oct 27.